DE69210078D1 - Umlagerungsverbindungen von Taxol und deren Verwendung bei der Bestimmung von in vivo-Aktivitäten - Google Patents

Umlagerungsverbindungen von Taxol und deren Verwendung bei der Bestimmung von in vivo-Aktivitäten

Info

Publication number
DE69210078D1
DE69210078D1 DE69210078T DE69210078T DE69210078D1 DE 69210078 D1 DE69210078 D1 DE 69210078D1 DE 69210078 T DE69210078 T DE 69210078T DE 69210078 T DE69210078 T DE 69210078T DE 69210078 D1 DE69210078 D1 DE 69210078D1
Authority
DE
Germany
Prior art keywords
taxol
ring
preferred
compounds
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69210078T
Other languages
German (de)
English (en)
Inventor
David G I Kingston
Gamini Samaranyake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virginia Tech Intellectual Properties Inc
Original Assignee
Virginia Tech Intellectual Properties Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virginia Tech Intellectual Properties Inc filed Critical Virginia Tech Intellectual Properties Inc
Application granted granted Critical
Publication of DE69210078D1 publication Critical patent/DE69210078D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69210078T 1991-03-18 1992-02-27 Umlagerungsverbindungen von Taxol und deren Verwendung bei der Bestimmung von in vivo-Aktivitäten Expired - Lifetime DE69210078D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67043291A 1991-03-18 1991-03-18

Publications (1)

Publication Number Publication Date
DE69210078D1 true DE69210078D1 (de) 1996-05-30

Family

ID=24690379

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69210078T Expired - Lifetime DE69210078D1 (de) 1991-03-18 1992-02-27 Umlagerungsverbindungen von Taxol und deren Verwendung bei der Bestimmung von in vivo-Aktivitäten

Country Status (5)

Country Link
EP (1) EP0505047B1 (https=)
JP (1) JPH0684364B2 (https=)
AT (1) ATE137229T1 (https=)
DE (1) DE69210078D1 (https=)
TW (1) TW223634B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994012198A1 (en) * 1992-11-27 1994-06-09 F.H. Faulding & Co. Limited Injectable taxol composition
AU5612694A (en) * 1992-11-27 1994-06-22 Napro Biotherapeutics, Inc. Injectable composition
US5973160A (en) 1992-12-23 1999-10-26 Poss; Michael A. Methods for the preparation of novel sidechain-bearing taxanes
GB9705903D0 (en) 1997-03-21 1997-05-07 Elliott Gillian D VP22 Proteins and uses thereof
CZ2003837A3 (cs) 2000-09-22 2004-12-15 Bristol-Myers Squibb Company Způsob pro snížení toxicity při kombinovaných chemoterapiích
US6919370B2 (en) 2000-11-28 2005-07-19 Transform Pharmaceuticals, Inc. Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
RU2021128415A (ru) 2016-09-06 2021-11-08 Мэйо Фаундейшн Фор Медикал Эдьюкейшн Энд Рисерч Композиции с паклитакселом, альбумином и связывающим средством и способы их применения и получения

Also Published As

Publication number Publication date
ATE137229T1 (de) 1996-05-15
JPH0684364B2 (ja) 1994-10-26
JPH0578342A (ja) 1993-03-30
EP0505047A1 (en) 1992-09-23
TW223634B (https=) 1994-05-11
EP0505047B1 (en) 1996-04-24

Similar Documents

Publication Publication Date Title
FI875732A0 (fi) Elektrokemoluminescens- analysfoerfaranden.
DE3576331D1 (de) Tetralin-derivate, ihre herstellung und verwendung.
AU1229088A (en) Novel cc-1065 analogs
ATE69221T1 (de) Verfahren zur synthese von 3-thia-4chinolonderivaten und zwischenprodukte dafuer und ihre verwendung als arzneimittel.
ATE129247T1 (de) 2- und 4-substituierte 1,3-dioxolane, deren synthese und verwendung.
ATE92746T1 (de) Polyether-abformmaterial, verfahren zu seiner herstellung und seine verwendung.
DE3783282D1 (de) Varianten von lav-viren, deren dns- und proteinkomponenten und deren verwendung, insbesondere zu diagnostischen zwecken und zur herstellung von immunogenen zusammensetzungen.
ATE56728T1 (de) Neue polypeptide mit alpha-amylase-hemmender wirkung, verfahren zu deren herstellung, deren verwendung und pharmazeutische praeparate.
DK15589A (da) Kemiske forbindelser
ATE90345T1 (de) Bis-naphthalimide, ihre herstellung und verwendung.
DE69210078D1 (de) Umlagerungsverbindungen von Taxol und deren Verwendung bei der Bestimmung von in vivo-Aktivitäten
ATE880T1 (de) 6 beta.7 beta; 15.16-dime thylen-1.4-androstadien-3-one, verfahren zu ihrer herstellung und verwendung als arzneimittel.
DE3650518D1 (de) Beta-Lactamantibiotika, Verfahren zur Herstellung und ihre Verwendung als und in Arzneimitteln
ATE126532T1 (de) Modifizierte protease, verfahren zu deren herstellung und diese enthaltende kosmetische zusammensetzungen.
ATE347592T1 (de) Rattenproteinkinase c und verfahren zur herstellung
IT8448702A0 (it) Impianto per la trasformazione biologica aerobica di materiali organici di rifiuto
DE68917660D1 (de) Harnstoffhaltige 2,4,6-Triaminopyrimidin-3-oxid-Derivate, deren Herstellung und deren Verwendung für Kosmetika und Hautpharmazie.
DE59010919D1 (de) N- und O-substituierte Aminophenolderivate, Zwischenprodukte zu deren Herstellung, deren Verwendung als Hydrolasesubstrate, ein entsprechendes Bestimmungsverfahren und hierfür geeignetes diagnostisches Mittel
ATE52505T1 (de) Epoxydierte isocyanate und verfahren zu ihrer herstellung.
DE59005199D1 (de) Verfahren zur Herstellung von Isothiocyanaten.
ATE59635T1 (de) 4-benzyloxy-3-pyrrolin-2-on, dessen herstellung und verwendung zur synthese von tetramsaeure.
ATE55123T1 (de) Alkylcarbonsaeureamide von pyridinalkylaminen, ihre herstellung und ihre verwendung als arzneimittel.
ATE58124T1 (de) Verfahren zur herstellung von 2,2-dimethyl-3formylcyclopropancarbonsaeurepentafluorphenylmethylester, und seine verwendung bei der herstellung von pestiziden produkten.
RU94027006A (ru) Способ получения 4-(гидроксиалкил)фенолов
ATE33020T1 (de) 10,11-dihydro-5h-dibenzo(a,d>cycloheptadienderivate, ihre herstellung und verwendung.

Legal Events

Date Code Title Description
8332 No legal effect for de